503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-7.13%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
51.26%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
-17.33%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
-10.98%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
11.31%
R&D change of 11.31% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
-100.00%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
-100.00%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
8.40%
Operating expenses growth less than half of CRWV's 17.97%. David Dodd would verify sustainability.
20.14%
Total costs growth 1.1-1.25x CRWV's 18.28%. Bill Ackman would demand justification.
No Data
No Data available this quarter, please select a different quarter.
-14.38%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-39.46%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-13.23%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-39.46%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-34.81%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-22.77%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-38.55%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-33.83%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-38.92%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-38.39%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-33.66%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-37.25%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-38.00%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-2.26%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-1.86%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.